Clinical Trial Update: Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 multi-center trial comparing ferric derisomaltose to no intravenous iron in iron-deficient patients with symptomatic chronic heart failure; currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Iron Deficiency

Drugs mentioned

• Ferric derisomaltose (ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Chronic Heart Failure, Iron Deficiencies | Phase 3 | Status: RECRUITING